REALDI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.773
EU - Europa 320
AS - Asia 286
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 3.384
Nazione #
US - Stati Uniti d'America 2.771
CN - Cina 271
FI - Finlandia 99
DE - Germania 75
SE - Svezia 52
IT - Italia 40
UA - Ucraina 20
GB - Regno Unito 17
IN - India 11
EU - Europa 4
FR - Francia 4
IE - Irlanda 3
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
NL - Olanda 2
DK - Danimarca 1
HR - Croazia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.384
Città #
Fairfield 365
Chandler 339
Houston 296
Jacksonville 263
Woodbridge 247
Wilmington 188
Ann Arbor 168
Ashburn 149
Cambridge 112
Seattle 108
Beijing 79
Princeton 74
Nanjing 54
Medford 50
Roxbury 41
San Diego 37
Helsinki 36
Des Moines 32
Boardman 24
Jiaxing 21
Shenyang 16
Changsha 13
Guangzhou 13
Nanchang 13
Hebei 10
Hefei 9
Norwalk 9
Redwood City 7
Jinan 6
New York 6
Kunming 5
London 4
Ningbo 4
Zhengzhou 4
Castrolibero 3
Dublin 3
Eboli 3
Tianjin 3
Venice 3
Capannoli 2
Costa Mesa 2
Fuzhou 2
Kharkiv 2
Kilburn 2
New Bedfont 2
Quzhou 2
San Jose 2
Serio 2
Silea 2
Taizhou 2
Tappahannock 2
Alghero 1
Amsterdam 1
Bologna 1
Brussels 1
Buffalo 1
Carcare 1
Chaoyang 1
Chengdu 1
Chicago 1
Chiswick 1
Columbus 1
Copenhagen 1
Falls Church 1
Florence 1
Girard 1
Hangzhou 1
Hyderabad 1
Indiana 1
Malolos 1
Martellago 1
Mestre 1
Miami Beach 1
Molise 1
Monmouth Junction 1
Mons 1
Nanning 1
Old Bridge 1
Pinehaven 1
Pioltello 1
Portland 1
Prague 1
Prato 1
Prescot 1
Pune 1
Riola 1
Rome 1
Scafati 1
Shanghai 1
Singapore 1
Sovicille 1
Taipei 1
Taiyuan 1
Torre del Greco 1
Venezia 1
Washington 1
Yenibosna 1
Zagreb 1
Zbuzany 1
Totale 2.889
Nome #
LONG-TERM OUTCOME OF CHRONIC TYPE-B HEPATITIS IN PATIENTS WHO ACQUIRE HEPATITIS-B VIRUS-INFECTION IN CHILDHOOD 115
null 115
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 113
ANTIBODY TO THE POLYALBUMIN (pHSA) RECEPTOR ON HEPATITIS B VIRUS IN ACUTE INFECTION AND IN VACCINE RECIPIENTS 106
Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship 98
Detection of immunoglobulins G and A on the cell membrane of hepatocytes from patients with alcoholic liver disease. 92
null 90
Split-brain syndrome after hepatic transplantation: a tacrolimus-related vasculitis? 80
Comparative histology of acute hepatitis B and non-A, non-B in Leuven and Padova. 80
REACTIVATION OF CHRONIC HEPATITIS B VIRUS INFECTION 79
Bone disease in primary hypercalciuria 78
CHARACTERIZATION OF LIVER HBV-DNA FORMS ASSOCIATED WITH HBeAg TO ANTI-HBe SEROCONVERSION 78
Virologic features of chronic hepatitis B virus infection in childhood. 77
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 74
NATURAL KILLER ACTIVITY IN PATIENTS WITH ACUTE VIRAL HEPATITIS 73
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 72
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 72
PREDICTIVE MARKERS OF CHRONICITY IN ACUTE HEPATITIS TYPE B 69
HEPATITIS B CORE AND E ANTIGENS IN THE LIVER BY IMMUNOFLUORESCENCE WITH MONOCLONAL ANTIBODIES 68
Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue. 66
"IN VITRO" LYMPHOCYTE RESPONSE TO HBcAg IN CHRONIC HBV INFECTION 62
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 61
EVOLUTION OF CHRONIC HEPATITIS B OF CHILDREN TOWARDS A "HEALTHY" HBsAg CARRIER STATE : RESULTS OF A PROSPECTIVE STUDY 58
OLGA Gastrits staging in young adults and country-specific Gastric Cancer Risk 57
ALTERAZIONI DELL'ATTIVITA' NATURAL KILLER IN CORSO DI INFEZIONE DA VIRUS EPATITICI 56
HEPATITIS B CORE (HBcAg) AND e (HBeAg) ANTIGENS IN THE LIVER DETECTED BY IMMUNOFLUORESCENCE WITH MONOCLONAL ANTIBODIES 55
Zoledronic acid decreases mRNA six-transmembrane epithelial antigen of prostate protein expression in prostate cancer cells 55
VIRUS RECEPTORS FOR POLYMERIZED HUMAN SERUM ALBUMIN (PHSA) IN HEPATITIS B VIRUS (HBV) INFECTION: DETECTION BY A SOLID PHASE RADIOIMMUNOASSAY (RIA) 54
PROBLEMS IN THE MANAGEMENT OF CHRONIC HEPATITIS-B WITH INTERFERON - EXPERIENCE IN A RANDOMIZED, MULTICENTER STUDY 54
MARCATORI DI INFEZIONE DA VIRUS B IN PAZIENTI CON EPATOPATIA CRONICA HBsAg NEGATIVA 50
Prognosis of chronic hepatitis B transmitted from HBsAg positive mothers. 49
HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM IN HEPATITIS B VIRUS (HBV) INFECTION. RELATION TO LIVER DAMAGE 49
ANTIGENE CORE NEL SIERO .DETERMINAZIONE E SIGNIFICATO IN PAZIENTI CON INFEZIONE ACUTA E CRONICA DA VIRUS DELL'EPATITE B 48
RECEPTORS FOR POLYMERIZED HUMAN SERUM ALBUMIN (pHSA) ON HEPATITIS B VIRUS (HBV) AND ANTI-RECEPTOR ANTIBODY IN HBV INFECTION 47
DETECTION OF HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM IN ACUTE AND CHRONIC HEPATITIS B VIRUS (HBV) INFECTION 47
BIOLOGIA MOLECOLARE APPLICATA AL VIRUS DELL'EPATITE B. STUDIO DEL DNA VIRALE NEL SIERO E NEL FEGATO E CORRELAZIONE CLINICA 46
STATE OF LIVER HBV-DNA IN CHRONIC INFECTION : RELATION TO HBeAg/anti-HBe SYSTEM 45
HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM OF PATIENTS WITH ACUTE AND CHRONIC HEPATITIS B VIRUS (HBV) INFECTION 43
RECEPTORS FOR POLYMERIZED HUMAN SERUM ALBUMIN ON HBV PARTICLES ELICIT AN ANTIBODY RESPONSE IN THE COURSE OF ACUTE HEPATITIS B 42
Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity 41
HBV-DNA NEL SIERO: RAPPORTI CON IL PROFILO SIEROLOGICO ED EVOLUTIVO IN CORSO DI INFEZIONE 40
CELLULAR IMMUNITY TO THE HEPATITIS B VIRION IN ACUTE HEPATITIS TYPE B 39
RIATTIVAZIONE DELL'EPATITE CRONICA DA VIRUS B, DOPO SIEROCONVERSIONE DA HBeAg AD ANTI-HBe 39
RECETTORI PER ALBUMINA UMANA POLIMERIZZATA SUL VIRUS DELL'EPATITE DI TIPO B: RAPPORTI CON L'ATTIVITA'REPLICATIVA DEL VIRUS 38
EPATITE DA VIRUS B: ESPRESSIONE DEL DNA VIRALE NEL SIERO E NEL FEGATO E CORRELAZIONI CON LO STATO DI MALATTIA 36
PATOGENESI IMMUNITARIA DELL'EPATITE DA VIRUS B 35
DIFFERENTI COMPORTAMENTI DELLE ALT NELL'EPATITE CRONICA B 35
Prevalenza e significato clinico dell’ipovitaminosi D in una divisione di medicina interna per acuti. 35
Favorable outcome in chronic active hepatitis caused by B virus in childhood. 34
TERAPIA IMMUNOSTIMOLANTE DELL'EPATITE CRONICA DA VIRUS B 31
CLINICAL RELEVANCE OF SERUM HBV-DNA TESTING IN PATIENTS WITH HBeAg POSITIVE INFECTION 31
Valutazione dell’apoptosi cellulare e dell’espressione della COX-2 nell’osteoporosi indotta da glucocorticoidi in ratti trattati con risedronato. 29
Un caso di osteosclerosi associata a HCV: effetti della terapia antivirale. 28
ATTIVITA' CITOTOSSICA DELLE CELLULE "NATURAL KILLER" NELL'EPATITE VIRALE 27
HBV-DNA NEI LINFOCIT 26
Iperparatiroidismo secondario persistente dopo trapianto di rene: effetti della terapia con colecalciferolo. 23
Ipovitaminosi D in una divisione di Medicina Interna per acuti. 23
Iperparatiroidismo secondario persistente dopo trapianto di rene: effetti scheletrici. 22
RECETTORI PER ALBUMINA UMANA POLIMERICA ED ANTICORPI ANTI- RECETTORE NELL'INFEZIONE DA HBV 20
Iperparatiroidismo secondario persistente dopo trapianto di rene: ruolo del CaSR e dell’ipovitaminosi D. 20
T-CELL SENSITIZATION TO HBcAg IN CHRONIC HBV INFECTION 19
Fever of unknown origin and monoclonal gammapathy of undertermined significance: description of two clinical cases with different pathology and different development (febbre di origine sconosciuta e gammopatia monoclonale di incerto significato. Descrizione di due casi clinici con differente patologia e diversa evoluzione) 16
Iperparatiroidismo secondario persistente dopo trapianto di rene: ruolo dell’ipovitaminosi D ed effetti della terapia. 16
Regenerative medicine: An insight 13
Trabecular bone microarchitecture in mild primary hyperparathyroidism 2
Totale 3.391
Categoria #
all - tutte 10.213
article - articoli 8.172
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019181 0 0 0 0 0 0 0 0 0 0 101 80
2019/2020799 142 16 7 33 62 43 102 75 76 135 58 50
2020/2021374 24 41 6 37 18 62 4 33 73 27 36 13
2021/2022592 9 105 35 41 24 53 23 55 27 10 67 143
2022/2023629 154 69 28 69 92 84 1 41 58 3 26 4
2023/2024122 7 33 26 12 13 8 11 4 2 6 0 0
Totale 3.391